港股异动 | 阜丰集团(00546)尾盘涨近5%创新高 公司与梅花生物达成和解 机构称未来行业格局有望改善

Group 1 - The stock of Fufeng Group (00546) rose nearly 5% to a historical high of 6.56 HKD following the announcement of a settlement with Meihua Biological [1][1] - Meihua Biological will pay 233 million CNY as a settlement to Fufeng Group, eliminating litigation risks for Meihua's xanthan gum business [1][1] - According to Everbright Securities, the global livestock industry's scale development and the growth of amino acid additives are promising, with leading companies like Fufeng Group expected to maintain market position through technological barriers and cost advantages [1][1] Group 2 - Shenyin Wanguo noted that with warming weather, the feed and breeding industry is expected to enter a small peak season, leading to a potential rebound in product prices [1][1] - The settlement between Fufeng and Meihua, both leading companies in the MSG and amino acid sectors, is anticipated to enhance collaboration in products like MSG, potentially improving the industry landscape and strengthening company profitability [1][1]